Drug Pricing in the News

Stay up to date on the latest drug pricing news.

News Spotlight

More in the News

Subscription Required

GoodRx, Leading PBMs Accused by Pharmacists of Price Fixing

Bloomberg Law
A consortium of Philadelphia pharmacists sued discount drug card aggregator GoodRx and the nation’s largest pharmacy benefit managers, alleging the companies employed anticompetitive practices, including price fixing, to restrain competition.
Read More >
Subscription Required

Same Drug, 2,200 Different Prices

Wall Street Journal
The cost of prescription drugs in the U.S. isn’t like the tabs for other products. The price for a single medicine can range by thousands of dollars depending on the drug plan.
Read More >

In PBM market, competition is hard to come by

AMA
Local PBM markets are on average highly concentrated—as defined by the U.S. Department of Justice (DOJ) and the Federal Trade Commission (FTC)—which suggests low competition among these pharmaceutical supply-chain middlemen.
Read More >
Subscription Required

F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices

The New York Times
The Federal Trade Commission has taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of inflating insulin prices and steering patients toward higher-cost insulin products to increase their profits.
Read More >